| Report Title | Price | Action |
|---|---|---|
| Sodium Channel Protein Type 5 Subunit Alpha (Sodium Channel Protein Cardiac Muscle Subunit Alpha or Voltage Gated Sodium Channel Subunit Alpha Nav1.5 or SCN5A) - Drugs in Development, 2021
Sodium Channel Protein Type 5 Subunit Alpha (Sodium Channel Protein Cardiac Muscle Subunit Alpha or Voltage Gated Sodium Channel Subunit Alpha Nav1.5 ...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Angiotensin Converting Enzyme 2 (ACE Related Carboxypeptidase or Metalloprotease MPROT15 or Angiotensin Converting Enzyme Homolog or ACE2 or EC 3.4.17.23) - Drugs in Development, 2021
Angiotensin Converting Enzyme 2 (ACE Related Carboxypeptidase or Metalloprotease MPROT15 or Angiotensin Converting Enzyme Homolog or ACE2 or EC 3.4.17...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Drugs in Development, 2021
GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Drugs in Development, 2021 Summary GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRA...
Published: Apr-2021 | No. of Pages: 130
|
$ 3000 | |
| Pouchitis (Gastrointestinal) - Drugs in Development, 2021
Pouchitis (Gastrointestinal) - Drugs in Development, 2021 Summary Pouchitis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Gastric Motility Disorder (Gastrointestinal) - Drugs in Development, 2021
Gastric Motility Disorder (Gastrointestinal) - Drugs in Development, 2021 Summary Gastric Motility Disorder (Gastrointestinal) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Tumor Necrosis Factor Receptor Superfamily Member 1B (Tumor Necrosis Factor Receptor 2 or p75 or p80 TNF Alpha Receptor or CD120b or TNFRSF1B) - Drugs in Development, 2021
Tumor Necrosis Factor Receptor Superfamily Member 1B (Tumor Necrosis Factor Receptor 2 or p75 or p80 TNF Alpha Receptor or CD120b or TNFRSF1B) - Drugs...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Cells Expressing Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) - Drugs in Development, 2021
Cells Expressing Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| LanC Like Protein 2 (Testis Specific Adriamycin Sensitivity Protein or G Protein Coupled Receptor 69B or GPR69B or LANCL2) - Drugs in Development, 2021
LanC Like Protein 2 (Testis Specific Adriamycin Sensitivity Protein or G Protein Coupled Receptor 69B or GPR69B or LANCL2) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Progressive Familial Intrahepatic Cholestasis (Gastrointestinal) - Drugs in Development, 2021
Progressive Familial Intrahepatic Cholestasis (Gastrointestinal) - Drugs in Development, 2021 Summary Progressive Familial Intrahepatic Cholestasis ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Gastroesophageal (GE) Junction Carcinomas (Oncology) - Drugs in Development, 2021
Gastroesophageal (GE) Junction Carcinomas (Oncology) - Drugs in Development, 2021 Summary Gastroesophageal (GE) Junction Carcinomas (Oncology) - Dru...
Published: Apr-2021 | No. of Pages: 140
|
$ 2000 | |
| 5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxytryptamine Receptor 1C or Serotonin Receptor 2C or HTR2C) - Drugs in Development, 2021
5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxytryptamine Receptor 1C or Serotonin Receptor 2C or HTR2C) - Drugs in Development, 2021 Summary 5...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Cells Expressing Interleukin 13 Receptor Subunit Alpha 2 (Interleukin 13 Binding Protein or CD213a2 or IL13RA2) - Drugs in Development, 2021
Cells Expressing Interleukin 13 Receptor Subunit Alpha 2 (Interleukin 13 Binding Protein or CD213a2 or IL13RA2) - Drugs in Development, 2021 Summary ...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Drugs in Development, 2021
Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Drugs in Development, 2021 Summary Interleukin 17A (Cytotoxic T Ly...
Published: Apr-2021 | No. of Pages: 65
|
$ 3000 | |
| Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021 Summary Acid Sphingomyelinase Defici...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Gastrointestinal Radiation Toxicity (Toxicology) - Drugs in Development, 2021
Gastrointestinal Radiation Toxicity (Toxicology) - Drugs in Development, 2021 Summary Gastrointestinal Radiation Toxicity (Toxicology) - Drugs in De...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Cytokine Receptor Common Subunit Gamma (Interleukin 2 Receptor Subunit Gamma or GammaC or p64 or CD132 or IL2RG) - Drugs in Development, 2021
Cytokine Receptor Common Subunit Gamma (Interleukin 2 Receptor Subunit Gamma or GammaC or p64 or CD132 or IL2RG) - Drugs in Development, 2021 Summary...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Cells Expressing SLAM Family Member 7 (CD319 or Membrane Protein FOAP 12 or CD2 Like Receptor Activating Cytotoxic Cells or Novel Ly9 or Protein 19A or CD2 Subset 1 or CS1 or SLAMF7) - Drugs in Development, 2021
Cells Expressing SLAM Family Member 7 (CD319 or Membrane Protein FOAP 12 or CD2 Like Receptor Activating Cytotoxic Cells or Novel Ly9 or Protein 19A o...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Tumor Necrosis Factor Receptor Superfamily Member 10B (Death Receptor 5 or TNF Related Apoptosis Inducing Ligand Receptor 2 or TRAIL Receptor 2 or DR5 or CD262 or TNFRSF10B) - Drugs in Development, 2021
Tumor Necrosis Factor Receptor Superfamily Member 10B (Death Receptor 5 or TNF Related Apoptosis Inducing Ligand Receptor 2 or TRAIL Receptor 2 or DR5...
Published: Apr-2021 | No. of Pages: 65
|
$ 3000 | |
| Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021
Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021 Summary Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Deve...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Gastroparesis (Gastrointestinal) - Drugs in Development, 2021
Gastroparesis (Gastrointestinal) - Drugs in Development, 2021 Summary Gastroparesis (Gastrointestinal) - Drugs in Development, 2021 provides an over...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 |